Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 8, Issue 12
1 December 2002
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265

The Biology Behind

Targeting the Mitochondria: An Exciting New Approach to Myeloma Therapy: Commentary re: N. J. Bahlis et al., Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic Acid-mediated Depletion of Intracellular Glutathione for the Treatment of Relapsed/Refractory Multiple Myeloma. Clin. Cancer Res., 8: 3658-3668, 2002.
William S. Dalton
View articletitled, Targeting the Mitochondria: An Exciting New Approach to Myeloma Therapy<span class="subtitle-colon">: </span><span class="subtitle">Commentary re: N. J. Bahlis <strong><em>et al</em></strong>., Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic Acid-mediated Depletion of Intracellular Glutathione for the Treatment of Relapsed/Refractory Multiple Myeloma. Clin. Cancer Res., <strong><em>8:</em></strong> 3658-3668, 2002.</span>
Open the PDF for in another window

The Cooperative Group Bulletin Board

Testing of New Agents in Childhood Cancer Preclinical Models: Meeting Summary
Peter J. Houghton; Peter C. Adamson; Susan Blaney; Howard A. Fine; Richard Gorlick; Michelle Haber; Lee Helman; Steve Hirschfeld; Melinda G. Hollingshead; Mark A. Israel; Richard B. Lock; John M. Maris; Glenn Merlino; Wendy Patterson; C. Patrick Reynolds; Kevin Shannon; Alice Yu; John Yu; Malcolm A. Smith
View articletitled, Testing of New Agents in Childhood Cancer Preclinical Models<span class="subtitle-colon">: </span><span class="subtitle">Meeting Summary</span>
Open the PDF for in another window

Advances in Brief

Clinical Trials
Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic Acid-mediated Depletion of Intracellular Glutathione for the Treatment of Relapsed/Refractory Multiple Myeloma1
Nizar J. Bahlis; Jennifer McCafferty-Grad; Ileana Jordan-McMurry; Jim Neil; Isildinha Reis; Mohamed Kharfan-Dabaja; James Eckman; Mark Goodman; Hugo F. Fernandez; Lawrence H. Boise; Kelvin P. Lee
View articletitled, Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic Acid-mediated Depletion of Intracellular Glutathione for the Treatment of Relapsed/Refractory Multiple Myeloma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Molecular Oncology, Markers, Clinical Correlates
Correlation between Insulin-like Growth Factor-binding Protein-3 Promoter Methylation and Prognosis of Patients with Stage I Non-Small Cell Lung Cancer1
Yoon Soo Chang; Luo Wang; Diane Liu; Li Mao; Waun Ki Hong; Fadlo R. Khuri; Ho-Young Lee
View articletitled, Correlation between Insulin-like Growth Factor-binding Protein-3 Promoter Methylation and Prognosis of Patients with Stage I Non-Small Cell Lung Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window

Regular Articles

Clinical Trials
Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer1
Andreas M. Kaufmann; Peter L. Stern; Elaine M. Rankin; Harald Sommer; Volkmar Nuessler; Achim Schneider; Malcom Adams; Toli S. Onon; Thomas Bauknecht; Uwe Wagner; Karlijn Kroon; Julian Hickling; Christopher M. Boswell; Simon N. Stacey; Henry C. Kitchener; Jennifer Gillard; Jantien Wanders; John St. C. Roberts; Heinz Zwierzina
View articletitled, Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 <em>E6</em> and <em>E7</em> Genes, in Women with Progressive Cervical Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma1
Renato Lenzi; Michael Rosenblum; Claire Verschraegen; Andrzej P. Kudelka; John J. Kavanagh; Marshall E. Hicks; Eric A. Lang; Michael A. Nash; Lawrence B. Levy; Michael E. Garcia; Chris D. Platsoucas; James L. Abbruzzese; Ralph S. Freedman
View articletitled, Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Active Immunotherapy of Metastatic Melanoma with Allogeneic Melanoma Lysates and Interferon α
Ulka Vaishampayan; Judith Abrams; Denise Darrah; Vicky Jones; Malcolm S. Mitchell
View articletitled, Active Immunotherapy of Metastatic Melanoma with Allogeneic Melanoma Lysates and Interferon α
Open the PDF for in another window
A Phase I Study of the Natural Killer T-Cell Ligand α-Galactosylceramide (KRN7000) in Patients with Solid Tumors
Giuseppe Giaccone; Cornelis J. A. Punt; Yoshitaka Ando; Rita Ruijter; Nobusuke Nishi; Marlies Peters; B. Mary E. von Blomberg; Rik J. Scheper; Hans J. J. van der Vliet; Alfons J. M. van den Eertwegh; Marja Roelvink; Jos Beijnen; Heinz Zwierzina; Herbert M. Pinedo
View articletitled, A Phase I Study of the Natural Killer T-Cell Ligand α-Galactosylceramide (KRN7000) in Patients with Solid Tumors
Open the PDF for in another window
A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies
Eric H. Rubin; Dinesh P. de Alwis; Isabelle Pouliquen; Lisa Green; Phil Marder; Yong Lin; Rita Musanti; Stephanie L. Grospe; Sharon L. Smith; Deborah L. Toppmeyer; Judy Much; Michael Kane; Ajai Chaudhary; Christopher Jordan; Michael Burgess; Christopher A. Slapak
View articletitled, A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies
Open the PDF for in another window
A Phase I Trial of Escalating Doses of Trastuzumab Combined with Daily Subcutaneous Interleukin 2: Report of Cancer and Leukemia Group B 96611
Gini F. Fleming; Neal J. Meropol; Gary L. Rosner; Donna R. Hollis; William E. Carson, III; Michael Caligiuri; Joanne Mortimer; Katherine Tkaczuk; Robin Parihar; Richard L. Schilsky; Mark J. Ratain
View articletitled, A Phase I Trial of Escalating Doses of Trastuzumab Combined with Daily Subcutaneous Interleukin 2<span class="subtitle-colon">: </span><span class="subtitle">Report of Cancer and Leukemia Group B 9661<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup></span>
Open the PDF for in another window

Research Articles

Molecular Oncology, Markers, Clinical Correlates
Mitogen-actived Protein Kinase Activation Is an Early Event in Melanoma Progression1
Cynthia Cohen; Angel Zavala-Pompa; Judy H. Sequeira; Mamoru Shoji; Deborah G. Sexton; George Cotsonis; Francesca Cerimele; Baskaran Govindarajan; Nada Macaron; Jack L. Arbiser
View articletitled, Mitogen-actived Protein Kinase Activation Is an Early Event in Melanoma Progression<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Expression of TRAIL and TRAIL Receptors in Colon Carcinoma: TRAIL-R1 Is an Independent Prognostic Parameter1
Jörn Sträter; Ulf Hinz; Henning Walczak; Gunhild Mechtersheimer; Karin Koretz; Christian Herfarth; Peter Möller; Thomas Lehnert
View articletitled, Expression of TRAIL and TRAIL Receptors in Colon Carcinoma: TRAIL-R1 Is an Independent Prognostic Parameter<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Aberrant Promoter Methylation in Chinese Patients with Non-Small Cell Lung Cancer: Patterns in Primary Tumors and Potential Diagnostic Application in Bronchoalevolar Lavage1
Eunice C. Chan; Shui Y. Lam; Kenneth W. Tsang; Bing Lam; James C. M. Ho; Kin H. Fu; Wah K. Lam; Yok L. Kwong
View articletitled, Aberrant Promoter Methylation in Chinese Patients with Non-Small Cell Lung Cancer: Patterns in Primary Tumors and Potential Diagnostic Application in Bronchoalevolar Lavage<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Soluble Aminopeptidase N/CD13 in Malignant and Nonmalignant Effusions and Intratumoral Fluid1
Yvette van Hensbergen; Henk J. Broxterman; Roeland Hanemaaijer; Anita S. Jorna; Natascha A. van Lent; Henk M. W. Verheul; Herbert M. Pinedo; Klaas Hoekman
View articletitled, Soluble Aminopeptidase N/CD13 in Malignant and Nonmalignant Effusions and Intratumoral Fluid<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Quantification of Macrophage Migration Inhibitory Factor mRNA Expression in Non-Small Cell Lung Cancer Tissues and Its Clinical Significance
Makiko Tomiyasu; Ichiro Yoshino; Ryuichi Suemitsu; Tatsuro Okamoto; Keizo Sugimachi
View articletitled, Quantification of Macrophage Migration Inhibitory Factor mRNA Expression in Non-Small Cell Lung Cancer Tissues and Its Clinical Significance
Open the PDF for in another window
Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival1
Jose M. Silva; Javier Silva; Antonio Sanchez; Jose M. Garcia; Gemma Dominguez; Mariano Provencio; Luis Sanfrutos; Eugenia Jareño; Antonio Colas; Pilar España; Felix Bonilla
View articletitled, Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
ATP-binding Cassette Superfamily Transporter Gene Expression in Human Primary Ovarian Carcinoma1
Yoshihiro Ohishi; Yoshinao Oda; Takeshi Uchiumi; Hiroaki Kobayashi; Toshio Hirakawa; Shingo Miyamoto; Naoko Kinukawa; Hitoo Nakano; Michihiko Kuwano; Masazumi Tsuneyoshi
View articletitled, ATP-binding Cassette Superfamily Transporter Gene Expression in Human Primary Ovarian Carcinoma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations
Jaya M. Satagopan; Jeff Boyd; Noah D. Kauff; Mark Robson; Lauren Scheuer; Steven Narod; Kenneth Offit
View articletitled, Ovarian Cancer Risk in Ashkenazi Jewish Carriers of <strong><em>BRCA1</em></strong> and <strong><em>BRCA2</em></strong> Mutations
Open the PDF for in another window
p16INK4A Hypermethylation Detected by Fluorescent Methylation-specific PCR in Plasmas from Non-Small Cell Lung Cancer1
Alessandra Bearzatto; Davide Conte; Milo Frattini; Nadia Zaffaroni; Francesca Andriani; Debora Balestra; Luca Tavecchio; Maria Grazia Daidone; Gabriella Sozzi
View articletitled, <strong><em>p16</em></strong><sup><strong><em>INK4A</em></strong></sup> Hypermethylation Detected by Fluorescent Methylation-specific PCR in Plasmas from Non-Small Cell Lung Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Analysis of Gene Expression in Ductal Carcinoma in Situ of the Breast1
Adewale Adeyinka; Ethan Emberley; Yulian Niu; Linda Snell; Leigh C. Murphy; Heidi Sowter; Charles C. Wykoff; Adrian L. Harris; Peter H. Watson
View articletitled, Analysis of Gene Expression in Ductal Carcinoma <strong><em>in Situ</em></strong> of the Breast<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Clinical Significance of Insulin-like Growth Factor-binding Protein-3 Expression in Stage I Non-Small Cell Lung Cancer1
Yoon Soo Chang; Koo Gong; Shihua Sun; Diane Liu; Adel K. El-Naggar; Fadlo R. Khuri; Waun Ki Hong; Ho-Young Lee
View articletitled, Clinical Significance of Insulin-like Growth Factor-binding Protein-3 Expression in Stage I Non-Small Cell Lung Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
RANTES Expression Is a Predictor of Survival in Stage I Lung Adenocarcinoma1
Christopher J. Moran; Douglas A. Arenberg; Chiang-Ching Huang; Thomas J. Giordano; Dafydd G. Thomas; David E. Misek; Guoan Chen; Mark D. Iannettoni; Mark B. Orringer; Samir Hanash; David G. Beer
View articletitled, RANTES Expression Is a Predictor of Survival in Stage I Lung Adenocarcinoma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Rare Variants of ATM and Risk for Hodgkin’s Disease and Radiation-associated Breast Cancers1
Kenneth Offit; Shlomit Gilad; Shoshana Paglin; Prema Kolachana; Laila C. Roisman; Khedoudja Nafa; Vincent Yeugelewitz; Maria Gonzales; Mark Robson; Deborah McDermott; Heather Hanson Pierce; Noah D. Kauff; Paz Einat; Suresh Jhanwar; Jaya M. Satagopan; Carole Oddoux; Nathan Ellis; Rami Skaliter; Joachim Yahalom
View articletitled, Rare Variants of <em>ATM</em> and Risk for Hodgkin’s Disease and Radiation-associated Breast Cancers<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-3 Promoter Enhances Breast Cancer Susceptibility
Giorgio Ghilardi; Maria Luisa Biondi; Maria Caputo; Simona Leviti; Marco DeMonti; Emma Guagnellini; Roberto Scorza
View articletitled, A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-3 Promoter Enhances Breast Cancer Susceptibility
Open the PDF for in another window
Down-Regulation of PIK3CG, a Catalytic Subunit of Phosphatidylinositol 3-OH Kinase, by CpG Hypermethylation in Human Colorectal Carcinoma1
Shuho Semba; Nanami Itoh; Masafumi Ito; Emile M. Youssef; Masaru Harada; Toshiyuki Moriya; Wataru Kimura; Mitsunori Yamakawa
View articletitled, Down-Regulation of <strong><em>PIK3CG</em></strong>, a Catalytic Subunit of Phosphatidylinositol 3-OH Kinase, by CpG Hypermethylation in Human Colorectal Carcinoma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Preclinical Validation of a Monochrome Real-Time Multiplex Assay for Translocations in Childhood Acute Lymphoblastic Leukemia
Abdul K. Siraj; Ugur Ozbek; Sudha Sazawal; Sema Sirma; Georgina Timson; Abdallah Al-Nasser; Manorama Bhargava; Hassan El Solh; Kishor Bhatia; Marina I. Gutiérrez
View articletitled, Preclinical Validation of a Monochrome Real-Time Multiplex Assay for Translocations in Childhood Acute Lymphoblastic Leukemia
Open the PDF for in another window
Tissue Microarray Molecular Profiling of Early, Node-negative Adenocarcinoma of the Rectum: A Comprehensive Analysis
Axel Hoos; Aviram Nissan; Alexander Stojadinovic; Jinru Shia; Cyrus V. Hedvat; Denis H. Y. Leung; Philip B. Paty; David Klimstra; Carlos Cordon-Cardo; W. Douglas Wong
View articletitled, Tissue Microarray Molecular Profiling of Early, Node-negative Adenocarcinoma of the Rectum<span class="subtitle-colon">: </span><span class="subtitle">A Comprehensive Analysis</span>
Open the PDF for in another window
Loss of pRb2/p130 Expression Is Associated with Unfavorable Clinical Outcome in Lung Cancer1
Mario Caputi; Angela M. Groeger; Vincenzo Esposito; Antonio De Luca; Valeria Masciullo; Alessandro Mancini; Feliciano Baldi; Ernst Wolner; Antonio Giordano
View articletitled, Loss of pRb2/p130 Expression Is Associated with Unfavorable Clinical Outcome in Lung Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Microvessel Density, Expression of Estrogen Receptor α, MIB-1, p53, and c-erbB-2 in Inflammatory Breast Cancer
Nicole J. McCarthy; Xiaowei Yang; Ilona R. Linnoila; Maria J. Merino; Stephen M. Hewitt; Allyson L. Parr; Soonmyung Paik; Seth M. Steinberg; Dan P. Hartmann; Nejib Mourali; Paul H. Levine; Sandra M. Swain
View articletitled, Microvessel Density, Expression of Estrogen Receptor α, MIB-1, p53, and c-erbB-2 in Inflammatory Breast Cancer
Open the PDF for in another window
Genomic Loss of 18p Predicts an Adverse Clinical Outcome in Patients with High-Risk Breast Cancer1
Joan Climent; Jose A. Martinez-Climent; David Blesa; Maria J. Garcia-Barchino; Rosana Saez; Dolors Sánchez-Izquierdo; Pilar Azagra; Ana Lluch; Javier Garcia-Conde
View articletitled, Genomic Loss of 18p Predicts an Adverse Clinical Outcome in Patients with High-Risk Breast Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Experimental Therapeutics, Preclinical Pharmacology
Studies with CWR22 Xenografts in Nude Mice Suggest That ZD1839 May Have a Role in the Treatment of Both Androgen-dependent and Androgen-independent Human Prostate Cancer1
Francis M. Sirotnak; Yohung She; Fei Lee; Jing Chen; Howard I. Scher
View articletitled, Studies with CWR22 Xenografts in Nude Mice Suggest That ZD1839 May Have a Role in the Treatment of Both Androgen-dependent and Androgen-independent Human Prostate Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Interleukin 15 Promotes Antigen-independent in Vitro Expansion and Long-Term Survival of Antitumor Cytotoxic T Lymphocytes1
Jun Lu; Robert L. Giuntoli, II; Ryusuke Omiya; Hiroya Kobayashi; Richard Kennedy; Esteban Celis
View articletitled, Interleukin 15 Promotes Antigen-independent <strong><em>in Vitro</em></strong> Expansion and Long-Term Survival of Antitumor Cytotoxic T Lymphocytes<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Screening of HLA-A24-restricted Epitope Peptides from Prostate-specific Membrane Antigen That Induce Specific Antitumor Cytotoxic T Lymphocytes1
Yutaka Horiguchi; Ikuei Nukaya; Kazuhide Okazawa; Ichiro Kawashima; John Fikes; Allesandro Sette; Masaaki Tachibana; Kazutoh Takesako; Masaru Murai
View articletitled, Screening of HLA-A24-restricted Epitope Peptides from Prostate-specific Membrane Antigen That Induce Specific Antitumor Cytotoxic T Lymphocytes<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Effectiveness of Ecteinascidin-743 against Drug-sensitive and -resistant Bone Tumor Cells1
Katia Scotlandi; Stefania Perdichizzi; Maria Cristina Manara; Massimo Serra; Stefania Benini; Vanessa Cerisano; Rosaria Strammiello; Mario Mercuri; Gemma Reverter-Branchat; Glynn Faircloth; Maurizio D’Incalci; Piero Picci
View articletitled, Effectiveness of Ecteinascidin-743 against Drug-sensitive and -resistant Bone Tumor Cells<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Pattern of Antitumor Activity of a Novel Camptothecin, ST1481, in a Large Panel of Human Tumor Xenografts1
Graziella Pratesi; Michelandrea De Cesare; Nives Carenini; Paola Perego; Sabina C. Righetti; Carla Cucco; Lucio Merlini; Claudio Pisano; Sergio Penco; Paolo Carminati; Loredana Vesci; Franco Zunino
View articletitled, Pattern of Antitumor Activity of a Novel Camptothecin, ST1481, in a Large Panel of Human Tumor Xenografts<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Docetaxel Induced Gene Expression Patterns in Head and Neck Squamous Cell Carcinoma Using cDNA Microarray and PowerBlot1
George H. Yoo; Marie P. Piechocki; John F. Ensley; Tam Nguyen; Jeffery Oliver; Hong Meng; Danny Kewson; Terry Y. Shibuya; Fulvio Lonardo; Michael A. Tainsky
View articletitled, Docetaxel Induced Gene Expression Patterns in Head and Neck Squamous Cell Carcinoma Using cDNA Microarray and PowerBlot<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
The Novel Antimicrotubule Agent Cryptophycin 52 (LY355703) Induces Apoptosis via Multiple Pathways in Human Prostate Cancer Cells1
Lisa Drew; Robert L. Fine; Tamara N. Do; Geoffrey P. Douglas; Daniel P. Petrylak
View articletitled, The Novel Antimicrotubule Agent Cryptophycin 52 (LY355703) Induces Apoptosis via Multiple Pathways in Human Prostate Cancer Cells<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Neuregulin Expression, Function, and Signaling in Human Ovarian Cancer Cells
Lynn M. R. Gilmour; Kenneth G. Macleod; Alison McCaig; Jane M. Sewell; William J. Gullick; John F. Smyth; Simon P. Langdon
View articletitled, Neuregulin Expression, Function, and Signaling in Human Ovarian Cancer Cells
Open the PDF for in another window
Effects of Glutamate Transporter Inhibitors on the Antitumor Activity of Doxorubicin
Yasuyuki Sadzuka; Yasuyo Yamashita; Takashi Sonobe
View articletitled, Effects of Glutamate Transporter Inhibitors on the Antitumor Activity of Doxorubicin
Open the PDF for in another window
Promising Preclinical Activity of 2-Methoxyestradiol in Multiple Myeloma1
David Dingli; Michael Timm; Stephen J. Russell; Thomas E. Witzig; S. Vincent Rajkumar
View articletitled, Promising Preclinical Activity of 2-Methoxyestradiol in Multiple Myeloma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Suradista NSC 651016 Inhibits the Angiogenic Activity of CXCL12-Stromal Cell-derived Factor 1α1
Gregory P. Schneider; Rosalba Salcedo; Hui Fang Dong; Hynda K. Kleinman; Joost J. Oppenheim; O. M. Zack Howard
View articletitled, Suradista NSC 651016 Inhibits the Angiogenic Activity of CXCL12-Stromal Cell-derived Factor 1α<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window

Retraction

Retraction
View articletitled, Retraction
Open the PDF for in another window

Acknowledgment to Reviewers

Acknowledgment to Reviewers
View articletitled, Acknowledgment to Reviewers
Open the PDF for in another window

Advertisement

Breaking
FDA Approves Drugs for MCL, Colorectal and Breast Cancers
NCI, NIH Directors Stepping Down
Pancreatic Cancer Survival Rate Stalls
View more recent articles
Latest News
Wildfires Spare Los Angeles Area Cancer Centers—For Now
Structural Variants Increase Risk of Pediatric Cancers
South Asian Scholars Urge Action on Cancer Inequities
View more recent articles
Research Watch
Bile Acids Modulate T-cell Response and Function in Liver Cancer
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept